Abiopharma

🔍 Aranki Karen L (Executive)

Company: Varex Imaging Corp (VREX)

Report Date: 2025-12-10

Detailed Transactions and Holdings:

• Acquired 6,665 shares of Common Stock (Direct)
  Date: 2025-12-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 6,842.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,923 shares of Common Stock at $11.7 per share (Direct)
  Date: 2025-12-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 4,919.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 6,665 shares of Restricted Stock Units (Derivative)
  Date: 2025-12-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 6,666.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
• Acquired 21,875 shares of Restricted Stock Units (Derivative)
  Date: 2025-12-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 21,875.00 | transaction_form_type: 4 | Footnotes: F1, F4, F4

Footnotes:

• F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis.
• F2: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.
• F3: These Restricted Stock Units granted on December 10, 2023 vested 50% on December 10, 2025, with the remaining 50% scheduled to vest 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest.
• F4: These Restricted Stock Units granted on December 10, 2025 are scheduled to vest 50% on December 10, 2027 and 50% on December 10, 2029. Vested shares will be delivered to the reporting person upon vest date.